Indivior Pharmaceuticals
INDV
INDV
76 hedge funds and large institutions have $1.91B invested in Indivior Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
22% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 23
Holders
76
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$49.4M | |
| 2 | +$45.5M | |
| 3 | +$43.7M | |
| 4 |
Credit Agricole
Montrouge Cedex,
France
|
+$21.8M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$8.79M |
Top Sellers
| 1 | -$29.2M | |
| 2 | -$9.77M | |
| 3 | -$7.88M | |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$3.85M |
| 5 |
JP Morgan Chase
New York
|
-$3.84M |